|
 |
FDA Approval Activities for this Drug…
Tracleer (Bosentan) Tablets, Actelion, Ltd. NDA 21-290/S1 10/6/03 10/10/03 10/10/03 Tracleer (Bosentan) Tablets, (Consumer Safety Alert) Actelion, Ltd. NDA 21-290 11/20/01 2/1/02 2/1/02 2/1/02 Tracleer Indications: Treatment of pulmonary arterial hypertension. | Tracleer (bosentan) Tablets, Actelion Ltd., Labeling Revision
For the most up-to-date approval information, please locate this API using the drug index. |
|
|